Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAT Receptor Occupancy of Long-acting Dexmethylphenidate in Healthy Adults
NCT00593138Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmethylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started Dec 2006; status: completed.
02
Drugs
dexmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00593138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593138.